Alishum Ali Appointed as Strategic Advisor for Commercialisation and Portfolio Growth

We are proud to announce the appointment of Alishum Ali as our new Strategic Advisor for Commercialisation. In this vital advisory role, Alishum will oversee the market translation, intellectual property scaling, and commercial trajectories of our capital-aligned portfolio companies and high-growth technology ventures.

His arrival brings a wealth of specialized expertise in bridging the gap between deep-tech innovation and institutional market readiness.

Driving High-Growth Venture Commercialisation

Bringing cutting-edge Data & AI technologies to market requires more than just capital—it requires an ironclad strategy for intellectual property protection, regulatory navigation, and market adoption. Alishum’s core focus will be working directly with our venture-backed spin-outs to accelerate their lifecycle from early-stage validation to scalable commercial entities.

Alishum brings over a decade of deep institutional experience inside the Western Australian innovation ecosystem. He has served as a Commercialisation Manager at the prestigious Perron Institute for Neurological and Translational Science and as a Healthcare & Life Sciences Commercialisation Consultant for Curtin University’s IP Commercialisation team.

His track record spans the entire technology transfer lifecycle:

• Structuring Commercial Deals: Developing robust licensing, spin-out structures, and joint-venture frameworks for sophisticated technologies.

• Assessing Innovation Readiness Levels (IRL): Ensuring our portfolio companies transition efficiently through technical milestones to attract tier-1 international investment.

• Navigating Complex Regulatory Pathways: Aligning deep-tech and advanced algorithmic solutions with rigid compliance governance.

A Stronger Foundation for Our Innovation Portfolio

By incorporating Alishum’s extensive background in structural commercialization and venture scaling, our company is significantly expanding the strategic support we offer to our ecosystem.

"Successful commercialisation is about transforming high-potential technology into a resilient, market-ready asset. Alishum’s rare combination of deep scientific understanding and elite corporate advisory experience ensures our high-growth ventures are built on a legally and commercially bulletproof foundation."

His unique perspective—shaped by navigating both the rigorous demands of advanced research institutions and the agile, high-stakes environments of tech startups—makes him the ideal advisor to position our portfolio companies as highly competitive, institutionally backed market leaders.

Looking Ahead

Alishum’s appointment comes at a pivotal moment as we scale our operations across Australia and Europe, alongside our strategic legal and industrial partners. With his advisory oversight guiding our commercialization strategies, we are uniquely equipped to maximize the economic and operational impact of our growing tech portfolio.

We are excited to welcome Alishum to the advisory team. We will continue to share operational milestones as our commercialization initiatives progress.